Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Treace Medical Concepts (TMCI) Stock Price & Analysis

TMCI Stock Chart & Stats

$4.56$0.13(2.93%)
At close: 11:12 AM EST
$4$4.5$510 Aug24 Aug8 Sep21 Sep5 Oct19 Oct2 Nov
Day’s Range
$4.24 - $4.82
52-Week Range
$1.17 - $6.65
Previous Close
$4.43
Volume
N/A
Average Volume (3M)
219.34K
Market Cap
$288.10M
Enterprise Value
$286.33M
Total Cash (Recent Filing)
$45.62M
Total Debt (Recent Filing)
$72.69M
Price to Earnings (P/E)
―
Beta
2.50
Next Earnings
Nov 06, 2026 (Est.)
EPS Estimate
-0.25
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Strong Gross Margins

Gross margins near 80% indicate strong product-level economics and meaningful pricing power in the current portfolio. This provides a foundation for operating leverage if revenue growth resumes, although sustained profitability still depends on controlling operating expenses and improving scale.

Improved Balance Sheet

Material debt reduction has strengthened Treace’s balance sheet and lowered financial leverage compared with prior years. Greater balance-sheet flexibility can support product investment and commercialization while reducing the burden of debt service as management works toward sustainable profitability.

Growing Surgeon Adoption

Rising adoption across the surgeon base suggests the newer bunion systems are expanding engagement rather than merely replacing existing products. Broader surgeon usage can increase procedure-related revenue, strengthen customer relationships, and create pull-through for the wider foot-and-ankle portfolio.

Bears Say

Persistent Losses And Cash Burn

Consistently negative operating and free cash flow show that the business has not yet converted its strong gross margins into self-funded operations. Continued cash consumption can constrain investment capacity and financial flexibility, making progress toward operating break-even a central determinant of durability.

Revenue And Mix Pressure

Revenue contraction combined with an unfavorable product mix creates pressure on both growth and average selling prices. If lower-priced procedures continue to gain share, the company may need sustained volume growth and successful new-product adoption to offset weaker per-case economics.

Execution-Dependent Recovery

The recovery plan depends on a stronger second half, seasonal Q4 demand, and successful commercialization of upcoming products. This concentrates near-term improvement in a limited period and leaves results vulnerable if adoption, launch timing, or procedure activity falls short of management’s expectations.

Treace Medical Concepts News

TMCI FAQ

What was Treace Medical Concepts’s price range in the past 12 months?
Treace Medical Concepts lowest stock price was $1.17 and its highest was $6.65 in the past 12 months.
What is Treace Medical Concepts’s market cap?
Treace Medical Concepts’s market cap is $288.10M.
When is Treace Medical Concepts’s upcoming earnings report date?
Treace Medical Concepts’s next earnings report is estimated for Nov 06, 2026 (not yet confirmed), which is in 3 days.
How were Treace Medical Concepts’s earnings last quarter?
Treace Medical Concepts released its earnings results on Aug 07, 2026. The company reported -$0.24 earnings per share for the quarter, beating the consensus estimate of -$0.298 by $0.058.
Is Treace Medical Concepts overvalued?
According to Wall Street analysts Treace Medical Concepts’s price is currently Undervalued.
Does Treace Medical Concepts pay dividends?
Treace Medical Concepts does not currently pay dividends.
What is Treace Medical Concepts’s EPS estimate?
Treace Medical Concepts’s EPS estimate is -0.25.
How many shares outstanding does Treace Medical Concepts have?
Treace Medical Concepts has 65,034,550 shares outstanding.
What happened to Treace Medical Concepts’s price movement after its last earnings report?
Treace Medical Concepts reported an EPS of -$0.24 in its last earnings report, beating expectations of -$0.298. Following the earnings report the stock price went up 8.676%.
Which hedge fund is a major shareholder of Treace Medical Concepts?
Hedge funds hold Treace Medical Concepts shares: the largest hedge-fund position in Treace Medical Concepts is 71,888,262 shares, and hedge funds decreased their holdings by 2.0M shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology